| For: | Zhai B, Yan HX, Liu SQ, Chen L, Wu MC, Wang HY. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas. World J Gastroenterol 2008; 14(37): 5665-5673 [PMID: 18837082 DOI: 10.3748/wjg.14.5665] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i37/5665.htm |
| Number | Citing Articles |
| 1 |
Hong Liu, Yan Ma, Hong-Wei He, Wu-Li Zhao, Rong-Guang Shao. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells. Autophagy 2017; 13(5) doi: 10.1080/15548627.2017.1291479
|
| 2 |
Yuzo Fujikura, J. Krijt, C. Povýšil, Z. Mělková, P. Přikryl, M. Vokurka, E. Nečas. Iron Overload Causes Alterations of E-Cadherin in the Liver. Folia Biologica 2016; 62(3) doi: 10.14712/fb2016062030095
|
| 3 |
Muhammad Usman, Zain ul Abedin, Zohaib Masih and
Asifa Kabir. Liver Cancer - Recent Advances [Working Title]. 2026; doi: 10.5772/intechopen.1014152
|
| 4 |
Franziska van Zijl, Gudrun Zulehner, Michaela Petz, Doris Schneller, Christoph Kornauth, Mara Hau, Georg Machat, Markus Grubinger, Heidemarie Huber, Wolfgang Mikulits. Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma. Future Oncology 2009; 5(8) doi: 10.2217/fon.09.91
|
| 5 |
Florence Grise, Sandra Sena, Aurélien Bidaud-Meynard, Jessica Baud, Jean-Baptiste Hiriart, Kassem Makki, Nathalie Dugot-Senant, Cathy Staedel, Paulette Bioulac-Sage, Jessica Zucman-Rossi, Jean Rosenbaum, Violaine Moreau. Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion. Hepatology 2012; 55(6) doi: 10.1002/hep.25568
|
| 6 |
Kosha J. Mehta, Paul A. Sharp. Iron elevates mesenchymal and metastatic biomarkers in HepG2 cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78348-5
|
| 7 |
Man Li, Hailing Lu, Xiaolian Liu, Qingwei Meng, Yanbin Zhao, Xuesong Chen, Jing Hu, Wei Liu, Li Cai. Overexpression of 14‑3‑3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.8742
|
| 8 |
Dong Chen, Yan Wang, Kejun Zhang, Xuelong Jiao, Bomin Yan, Jun Liang. Antisense Oligonucleotide Against Clusterin Regulates Human Hepatocellular Carcinoma Invasion Through Transcriptional Regulation of Matrix Metalloproteinase-2 and E-Cadherin. International Journal of Molecular Sciences 2012; 13(8) doi: 10.3390/ijms130810594
|
| 9 |
Lili Zhou, Tirthadipa Pradhan-Sundd, Minakshi Poddar, Sucha Singh, Alex Kikuchi, Donna B. Stolz, Weinian Shou, Zongfang Li, Kari N. Nejak-Bowen, Satdarshan P. Monga. Mice with Hepatic Loss of the Desmosomal Protein γ-Catenin Are Prone to Cholestatic Injury and Chemical Carcinogenesis. The American Journal of Pathology 2015; 185(12) doi: 10.1016/j.ajpath.2015.08.019
|
| 10 |
Alexandros Charalabopoulos, Christos Golias. E-cadherin expression in Barrett’s esophagus and esophageal carcinoma. Esophagus 2014; 11(3) doi: 10.1007/s10388-014-0424-x
|
| 11 |
Shuhua Zhao, Yuanyuan Zhang, Xiuxiu Zheng, Xiaolong Tu, Huanan Li, Jiangning Chen, Yuhui Zang, Junfeng Zhang. Loss of MicroRNA‐101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes. Journal of Cellular Physiology 2015; 230(11) doi: 10.1002/jcp.24995
|
| 12 |
Liang-yun Li, Jun-fa Yang, Fan Rong, Zhi-pan Luo, Shuang Hu, Hui Fang, Ying Wu, Rui Yao, Wei-hao Kong, Xiao-wen Feng, Bang-jie Chen, Jun Li, Tao Xu. ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway. Acta Pharmacologica Sinica 2021; 42(10) doi: 10.1038/s41401-020-00575-3
|
| 13 |
Regina Cheuk-Lam Lo, Irene Oi-Lin Ng. Hepatocellular tumors: Immunohistochemical analyses for classification and prognostication. Chinese Journal of Cancer Research 2011; 23(4) doi: 10.1007/s11670-011-0245-6
|
| 14 |
Tamara M H Gall, Adam E Frampton. Gene of the month: E-cadherin (CDH1). Journal of Clinical Pathology 2013; 66(11) doi: 10.1136/jclinpath-2013-201768
|
| 15 |
Antonio Saviano, Natascha Roehlen, Alessia Virzì, Armando Andres Roca Suarez, Yujin Hoshida, Joachim Lupberger, Thomas F. Baumert. Hepatocellular Carcinoma. Molecular and Translational Medicine 2019; doi: 10.1007/978-3-030-21540-8_15
|
| 16 |
Berik Rovgaliyev, Ming Yuan Tan, Kwang-Woong Lee, Seung Cheol Oh, Min Young Park, Sooin Seo, Hyo-Sun Choi, Suk Kyun Hong, Jae-Hyung Cho, Jeong-Moo Lee, Nam-Joon Yi, Kyung-Suk Suh. Sirolimus Attenuates Calcineurin Inhibitor-Induced Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Transplantation Proceedings 2022; 54(7) doi: 10.1016/j.transproceed.2022.04.027
|
| 17 |
Junfeng Li, Xiaopeng Dai, Hongfei Zhang, Wei Zhang, Shihui Sun, Tongtong Gao, Zhihua Kou, Hong Yu, Yan Guo, Lanying Du, Shibo Jiang, Jianying Zhang, Yusen Zhou. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin. Oncotarget 2015; 6(30) doi: 10.18632/oncotarget.5039
|
| 18 |
Nathalie Zucchini-Pascal, Ludovic Peyre, Roger Rahmani. Crosstalk between Beta-Catenin and Snail in the Induction of Epithelial to Mesenchymal Transition in Hepatocarcinoma: Role of the ERK1/2 Pathway. International Journal of Molecular Sciences 2013; 14(10) doi: 10.3390/ijms141020768
|
| 19 |
Hyunkyoung Lee, Min Jung Pyo, Seong Kyeong Bae, Yunwi Heo, Indu Choudhary, Duhyeon Hwang, Hyeryeon Yang, Je-hein Kim, Jinho Chae, Chang Hoon Han, Changkeun Kang, Seungshic Yum, Euikyung Kim. Nemopilema nomurai jellyfish venom exerts an anti-metastatic effect by inhibiting Smad- and NF-κB-mediated epithelial–mesenchymal transition in HepG2 cells. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20724-3
|
| 20 |
Xuejun Kuang, Jiye Zhu, Zhao Peng, Jianjun Wang, Zhigang Chen. Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2016; 61(2) doi: 10.1007/s10620-015-3879-2
|
| 21 |
Lili Wang, Lexun Xue, Hongxia Yan, Jie Li, Yucheng Lu. Effects of ROCK inhibitor, Y-27632, on adhesion and mobility in esophageal squamous cell cancer cells. Molecular Biology Reports 2010; 37(4) doi: 10.1007/s11033-009-9645-9
|
| 22 |
Vladimír Bartoš, Milada Kullová. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin. Acta Medica (Hradec Kralove, Czech Republic) 2017; 60(1) doi: 10.14712/18059694.2017.48
|
| 23 |
Mary E. Landmesser, Wesley M. Raup-Konsavage, Heather L. Lehman, Douglas B. Stairs, Claudia D. Andl. Loss of p120ctn causes EGFR-targeted therapy resistance and failure. PLOS ONE 2020; 15(10) doi: 10.1371/journal.pone.0241299
|
| 24 |
Bang-Hao Xu, Jing-Hang Jiang, Tao Luo, Zhi-Jun Jiang, Xin-Yu Liu, Le-Qun Li. Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma. Medicine 2021; 100(30) doi: 10.1097/MD.0000000000026762
|
| 25 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2) doi: 10.1016/j.critrevonc.2011.05.005
|
| 26 |
Igor P. Pogribny, Ivan Rusyn. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Letters 2014; 342(2) doi: 10.1016/j.canlet.2012.01.038
|
| 27 |
Anja Konzack, Mirza Jakupovic, Kateryna Kubaichuk, Agnes Görlach, Frank Dombrowski, Ilkka Miinalainen, Raija Sormunen, Thomas Kietzmann. Mitochondrial Dysfunction Due to Lack of Manganese Superoxide Dismutase Promotes Hepatocarcinogenesis. Antioxidants & Redox Signaling 2015; 23(14) doi: 10.1089/ars.2015.6318
|
| 28 |
Xin Chen, Hong Wang, Dandan Li, Yuan Yu, Jinfang Zhi. The effect of carboxylated nanodiamond (cNDs) on the migration of HepG2 cells. physica status solidi (a) 2016; 213(8) doi: 10.1002/pssa.201600094
|
| 29 |
Zong-Sheng Sun, Chang-Lei Li, Han-Hui Jing, Zheng-Zhao Wang, Long-Bo Zheng. ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes. World Journal of Gastrointestinal Oncology 2026; 18(5): 116163 doi: 10.4251/wjgo.v18.i5.116163
Abstract(33) |
Core Tip(31) |
Full Article(HTML)(85)
|
Full Article (PDF)-37856K(11)
|
Full Article with Cover (PDF)-38177K(13)
|
Full Article (XML)-134K(8)
|
Audio-919K(1)
|
Peer-Review Report-217K(8)
|
Answering Reviewers-79K(6)
|
Supplementary Material-181K(5)
|
Times Cited (0)
|
Total Visits (185)
|
Open
|
| 30 |
J. Sun, D. Zhang, D.-H. Bae, S. Sahni, P. Jansson, Y. Zheng, Q. Zhao, F. Yue, M. Zheng, Z. Kovacevic, D. R. Richardson. Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors. Carcinogenesis 2013; 34(9) doi: 10.1093/carcin/bgt163
|
| 31 |
Simona Gurzu, Laszlo Kobori, Decebal Fodor, Ioan Jung. Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review. BioMed Research International 2019; 2019 doi: 10.1155/2019/2962580
|
| 32 |
Nanhong Tang, Qun Xie, Xiaoqian Wang, Xiujin Li, Yanlin Chen, Xu Lin, Jianyin Lin. Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and Epithelial-Mesenchymal Transition. Archives of Pharmacal Research 2011; 34(5) doi: 10.1007/s12272-011-0512-6
|
| 33 |
D. Firrincieli, M. Boissan, N. Chignard. Epithelial-mesenchymal transition in the liver. Gastroentérologie Clinique et Biologique 2010; 34(10) doi: 10.1016/j.gcb.2010.04.017
|
| 34 |
Yuehua Zhao, Hao Lin, Jingwei Jiang, Mengxi Ge, Xiaohua Liang. TBL1XR1 as a potential therapeutic target that promotes epithelial‑mesenchymal transition in lung squamous cell carcinoma. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6955
|
| 35 |
Abdel Hady A. Abdel Wahab, Manal M. Hussein, Samia A. Shouman, Dalia Fouad, Mohamed H. Kobaisi, Ola EL Habit. Role of let7-g and miR-221 level as potential predictors for overall survival of hepatocellular carcinoma patients. Arab Journal of Gastroenterology 2022; 23(3) doi: 10.1016/j.ajg.2022.03.001
|
| 36 |
Carolina Noronha, Ana Sofia Ribeiro, Ricardo Taipa, Diogo S. Castro, Joaquim Reis, Cláudia Faria, Joana Paredes. Cadherin Expression and EMT: A Focus on Gliomas. Biomedicines 2021; 9(10) doi: 10.3390/biomedicines9101328
|
| 37 |
Jolanda van Hengel, Celine Van den Broeke, Tim Pieters, Louis Libbrecht, Ilse Hofmann, Frans van Roy. Inactivation of p120 catenin in mice disturbs intrahepatic bile duct development and aggravates liver carcinogenesis. European Journal of Cell Biology 2016; 95(12) doi: 10.1016/j.ejcb.2016.10.003
|
| 38 |
Longbo Zheng, Ming Xu, Junjie Xu, Ke Wu, Qian Fang, Yuelong Liang, Senjun Zhou, Dong Cen, Lin Ji, Weili Han, Xiujun Cai. ELF3 promotes epithelial–mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma. Cell Death & Disease 2018; 9(3) doi: 10.1038/s41419-018-0399-y
|
| 39 |
Sajith Nair, Devaki S Arathy, Aneesh Issac, Easwaran Sreekumar. Differential gene expression analysis of in vitro duck hepatitis B virus infected primary duck hepatocyte cultures. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-363
|
| 40 |
Svetlana N. Rubtsova, Irina Y. Zhitnyak, Natalya A. Gloushankova. Phenotypic Plasticity of Cancer Cells Based on Remodeling of the Actin Cytoskeleton and Adhesive Structures. International Journal of Molecular Sciences 2021; 22(4) doi: 10.3390/ijms22041821
|
| 41 |
Massimiliano Berretta, Carla Cavaliere, Lara Alessandrini, Brigida Stanzione, Gaetano Facchini, Luca Balestreri, Tiziana Perin, Vincenzo Canzonieri. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget 2017; 8(8) doi: 10.18632/oncotarget.13929
|
| 42 |
Jiang Chen, Jinghua Liu, Renan Jin, Jiliang Shen, Yuelong Liang, Rui Ma, Hui Lin, Xiao Liang, Hong Yu, Xiujun Cai, Andreas Krieg. Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2014; 9(11) doi: 10.1371/journal.pone.0111885
|
| 43 |
Huakan Zhao, Fenglin Lv, Guizhao Liang, Xiaobin Huang, Gang Wu, Wenfa Zhang, Le Yu, Lei Shi, Yong Teng. FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β- catenin signaling cascade via FGFR4 activation. Oncotarget 2016; 7(12) doi: 10.18632/oncotarget.6185
|
| 44 |
Luc Gailhouste. Liver Stem Cells. Methods in Molecular Biology 2012; 826 doi: 10.1007/978-1-61779-468-1_4
|
| 45 |
Heather L. Lehman, Michal Kidacki, Douglas B. Stairs. Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75866-0
|
| 46 |
Xianteng Wang, Hao Wang, Guosheng Li, Yonghong Song, Shurong Wang, Faliang Zhu, Chun Guo, Lining Zhang, Yongyu Shi. Activated macrophages down-regulate expression of E-cadherin in hepatocellular carcinoma cells via NF–κB/Slug pathway. Tumor Biology 2014; 35(9) doi: 10.1007/s13277-014-2159-7
|
| 47 |
Gerhard F Huber, Lena Züllig, Alex Soltermann, Matthias Roessle, Nicole Graf, Stephan K Haerle, Gabriela Studer, Wolfram Jochum, Holger Moch, Sandro J Stoeckli. Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-217
|
| 48 |
Michal Kielbik, Izabela Szulc-Kielbik, Magdalena Klink. E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian Cancer. International Journal of Molecular Sciences 2022; 23(22) doi: 10.3390/ijms232214383
|
| 49 |
Rachel Purcell, Margaret Childs, Rudolf Maibach, Carina Miles, Clinton Turner, Arthur Zimmermann, Piotra Czauderna, Michael Sullivan. Potential biomarkers for hepatoblastoma: Results from the SIOPEL-3 study. European Journal of Cancer 2012; 48(12) doi: 10.1016/j.ejca.2011.10.019
|
| 50 |
María L. Bacigalupo, Malena Manzi, María V. Espelt, Lucas D. Gentilini, Daniel Compagno, Diego J. Laderach, Carlota Wolfenstein‐Todel, Gabriel A. Rabinovich, María F. Troncoso. Galectin‐1 Triggers Epithelial‐Mesenchymal Transition in Human Hepatocellular Carcinoma Cells. Journal of Cellular Physiology 2015; 230(6) doi: 10.1002/jcp.24865
|
| 51 |
Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng. Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Critical Reviews in Oncology/Hematology 2015; 94(3) doi: 10.1016/j.critrevonc.2015.01.009
|
| 52 |
Emily Diane Wickline, Yu Du, Donna B. Stolz, Michael Kahn, Satdarshan P.S. Monga. γ-Catenin at Adherens Junctions: Mechanism and Biologic Implications in Hepatocellular Cancer after β-Catenin Knockdown. Neoplasia 2013; 15(4) doi: 10.1593/neo.122098
|
| 53 |
Subhayan Sur, Debolina Pal, Kaustav Banerjee, Suvra Mandal, Ashes Das, Anup Roy, Chinmay Kumar Panda. Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model. Molecular Carcinogenesis 2016; 55(7) doi: 10.1002/mc.22356
|
| 54 |
A.L. Jones, A. Suárez-Bonnet, J.A. Mitchell, G.A. Ramirez, M.F. Stidworthy, S.L. Priestnall. Avian Papilloma and Squamous Cell Carcinoma: a Histopathological, Immunohistochemical and Virological study. Journal of Comparative Pathology 2020; 175 doi: 10.1016/j.jcpa.2019.11.007
|
| 55 |
Jiřina Procházková, Markéta Kabátková, Lenka Šmerdová, Jiří Pacherník, Dominika Sýkorová, Jiří Kohoutek, Pavlína Šimečková, Eva Hrubá, Alois Kozubík, Miroslav Machala, Jan Vondráček. Aryl Hydrocarbon Receptor Negatively Regulates Expression of the Plakoglobin Gene (Jup). Toxicological Sciences 2013; 134(2) doi: 10.1093/toxsci/kft110
|
| 56 |
Cong-Li Jia, Fu Yang, Rui-Ning Li. Identification of Potential Core Genes Between Primary and Metastatic Malignant Melanoma and Analysis of Their Immune Correlation. International Journal of General Medicine 2022; doi: 10.2147/IJGM.S338890
|
| 57 |
Hye-Sun Choi, Seon-Hee Yim, Hai-Dong Xu, Seung-Hyun Jung, Seung-Hun Shin, Hae-Jin Hu, Chan-Kwon Jung, Jong Young Choi, Yeun-Jun Chung. Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-122
|
| 58 |
Fausto J. Rodriguez, Laura J. Lewis-Tuffin, Panos Z. Anastasiadis. E-cadherin's dark side: Possible role in tumor progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1826(1) doi: 10.1016/j.bbcan.2012.03.002
|
| 59 |
Luis Fernando Méndez-López, Ana Laura de la Garza Hernández, Manuel López-Cabanillas Lomelí. Pathophysiology of Cancer: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2024; 22 doi: 10.1007/16833_2024_324
|
| 60 |
Jennifer Pasquier, Nadine Abu-Kaoud, Haya Al Thani, Arash Rafii. Epithelial to Mesenchymal Transition in a Clinical Perspective. Journal of Oncology 2015; 2015 doi: 10.1155/2015/792182
|
| 61 |
Agnieszka Dominiak, Beata Chełstowska, Wioletta Olejarz, Grażyna Nowicka. Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions. Cancers 2020; 12(5) doi: 10.3390/cancers12051232
|
| 62 |
Mohan Krishna Ghanta, Mohammad Faiz Hussain, Asmita Karnalkar, Sirpu Natesh Nagabhishek, Poojith Nuthalapati, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00003-3
|
| 63 |
Natalya A. Gloushankova, Svetlana N. Rubtsova, Irina Y. Zhitnyak. Cadherin-mediated cell-cell interactions in normal and cancer cells. Tissue Barriers 2017; 5(3) doi: 10.1080/21688370.2017.1356900
|
| 64 |
Jiang Chen, Jie Zhao, Rui Ma, Hui Lin, Xiao Liang, Xiujun Cai, Kwan Man. Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2014; 9(8) doi: 10.1371/journal.pone.0103952
|
| 65 |
Yingying Zhu, Yajing He, Runliang Gan. Wnt Signaling in Hepatocellular Carcinoma: Biological Mechanisms and Therapeutic Opportunities. Cells 2024; 13(23) doi: 10.3390/cells13231990
|